Search
Menu
Zurich Instruments AG - Boost Your Optics 1-24 LB

Schering AG

Facebook X LinkedIn Email
Schering AG of Berlin and Avid Radiopharmaceuticals Inc. of Philadelphia are collaborating to develop diagnostic imaging agents for Alzheimer’s. The compounds, made by Avid, bind to amyloid plaques in the brain, which are thought to cause the disease. The compounds can be used with noninvasive imaging techniques such as PET. Under the agreement, Schering has the option to assume exclusive rights for the development and commercialization of such compounds for use with PET.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: September 2006
    BiophotonicsBusinessRapidScan

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.